Results 211 to 220 of about 39,736 (269)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients. [PDF]

open access: yesSci Rep
Pino-González M   +8 more
europepmc   +1 more source

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy. [PDF]

open access: yesFront Oncol
Trachu N   +13 more
europepmc   +1 more source

Environmental change shapes understory plant diversity and dominance in boreal forests. [PDF]

open access: yesNat Commun
Chen X   +6 more
europepmc   +1 more source

Soil pH mediates the impact of pesticides on bacterial communities, diversity, and abundance. [PDF]

open access: yesFront Microbiol
Némethová E   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy